CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,088,801
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-12-08 | Lewis Michael Director | Purchase | +394,918 | $11.00 | $4.3M | 1,934,490 |
| 2014-12-08 | Lewis Michael Director | Other disposition | −17,383 | 1,917,107 | ||
| 2014-12-08 | Lewis Michael Director | Conversion · Series A Preferred Stock | −747,000 | 0 | ||
| 2014-12-08 | Lewis Michael Director | Conversion · Series A-1 Preferred Stock | −492,618 | 0 | ||
| 2014-12-08 | Lewis Michael Director | Option exercise · Common Stock Warrant (Right to Buy) | −11,502 | 0 |
Page 27 of 27 · 525 trades